Back to search results

Mediterranean Diet for Inflammatory Bowel Disease

This study is looking into how a Mediterranean Diet affects inflammatory bowel disease (IBD). Researchers want to see if this diet can help reduce the severity of IBD. You might be able to join if you are 18 or older and have mild to moderate Crohn's Disease, with specific inflammation markers (Crohn's disease activity index between 150-450, and fecal calprotectin over 250). The main goal is to measure changes in your Crohn's Disease Activity Index after 42 days on the diet. This study is currently unclear on its recruitment status.

Study design
This is an interventional study planning to enroll 90 participants. It is not specified if it is randomized or blinded.
What's involved
You would follow a Mediterranean Diet for 42 days. Blood and stool samples will be collected before and after the diet changes.
Compensation
Not stated in the trial record.
Follow-up
Your disease activity will be measured at 42 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05973500

Effect of Mediterranean Diet in Inflammatory Bowel Disease

Recruiting
NAAges 18+InterventionalTreatment
University of California, San Diego
~90 participants
Updated 2024-04-02 on ClinicalTrials.gov
What's tested:Mediterranean Diet

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
short Crohn's Disease Activity Index (sCDAI)
Measured over 42 Days

Conditions

Inflammatory Bowel Disease

Explore related trials

Crohn Disease

Where it's being run

1 sites across 1 states
California1

Who to contact

Monica Guma, M.D., PhD
[email protected]
8588226523
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years old or older
Meet classification criteria for inflammatory bowel disease including those with mild to moderate Crohn's Disease as defined by a Crohn's disease activity index between 150-450, with fecal calprotectin\>250, within 1 month of enrollment.

Exclusion

Unable to provide informed consent
History of or current drug abuse
Pregnancy
Start or change in dose of standard-of-care treatment within 12 weeks of the screening
Known allergy to any component of the proposed diet
Subjects with significant other medical or psychiatric comorbidities and /or medication use which in
physician's clinical judgment might difficult the interpretation of the results
Patients that are not on a stable dose of medications, for instance, steroids, in between samples collection
Patients on antibiotics
Patients with C difficile infection within 4 weeks of enrollment

What this trial measures

  • short Crohn's Disease Activity Index (sCDAI)42 Days

    Mild to moderate Crohn's Disease is defined by a short Crohn's Disease activity index (sCDAI) between 150-450, while those in remission from Crohn's Disease have an sCDAI score below 150. An sCDAI score exceeding 450 is used as a marker of severe Crohn's Disease.